Identification of an allosteric benzothiazolopyrimidone inhibitor of the oncogenic protein tyrosine phosphatase SHP2

doi:10.1016/j.bmc.2017.10.025

Title: Identification of an allosteric benzothiazolopyrimidone inhibitor of the oncogenic protein tyrosine phosphatase SHP2

Full Record
Other Related Research

Authors:: LaRochelle, Jonathan R.; Fodor, Michelle; Ellegast, Jana M.; Liu, Xiaoxi; Vemulapalli, Vidyasiri; Mohseni, Morvarid; Stams, Travis; Buhrlage, Sara J.; Stegmaier, Kimberly; LaMarche, Matthew J.; Acker, Michael G.; Blacklow, Stephen C.

Publication Date:: 2017-12-01

Sponsoring Org.:: USDOE

OSTI Identifier:: 1496372

Grant/Contract Number:: DEAC02-06CH11357

Resource Type:: Publisher's Accepted Manuscript

Journal Name:: Bioorganic and Medicinal Chemistry

Additional Journal Information:: Journal Name: Bioorganic and Medicinal Chemistry Journal Volume: 25 Journal Issue: 24; Journal ID: ISSN 0968-0896

Publisher:: Elsevier

Country of Publication:: United Kingdom

Language:: English

Citation Formats


                    LaRochelle, Jonathan R., Fodor, Michelle, Ellegast, Jana M., Liu, Xiaoxi, Vemulapalli, Vidyasiri, Mohseni, Morvarid, Stams, Travis, Buhrlage, Sara J., Stegmaier, Kimberly, LaMarche, Matthew J., Acker, Michael G., and Blacklow, Stephen C. Identification of an allosteric benzothiazolopyrimidone inhibitor of the oncogenic protein tyrosine phosphatase SHP2.  United Kingdom: N. p., 2017. 
        Web.  doi:10.1016/j.bmc.2017.10.025.

Copy to clipboard


                    LaRochelle, Jonathan R., Fodor, Michelle, Ellegast, Jana M., Liu, Xiaoxi, Vemulapalli, Vidyasiri, Mohseni, Morvarid, Stams, Travis, Buhrlage, Sara J., Stegmaier, Kimberly, LaMarche, Matthew J., Acker, Michael G., & Blacklow, Stephen C. Identification of an allosteric benzothiazolopyrimidone inhibitor of the oncogenic protein tyrosine phosphatase SHP2.  United Kingdom.  doi:10.1016/j.bmc.2017.10.025.

Copy to clipboard


                    LaRochelle, Jonathan R., Fodor, Michelle, Ellegast, Jana M., Liu, Xiaoxi, Vemulapalli, Vidyasiri, Mohseni, Morvarid, Stams, Travis, Buhrlage, Sara J., Stegmaier, Kimberly, LaMarche, Matthew J., Acker, Michael G., and Blacklow, Stephen C. Fri .  
        "Identification of an allosteric benzothiazolopyrimidone inhibitor of the oncogenic protein tyrosine phosphatase SHP2".  United Kingdom.  doi:10.1016/j.bmc.2017.10.025.

Copy to clipboard


                    
@article{osti_1496372,

  title        = {Identification of an allosteric benzothiazolopyrimidone inhibitor of the oncogenic protein tyrosine phosphatase SHP2},

  author       = {LaRochelle, Jonathan R. and Fodor, Michelle and Ellegast, Jana M. and Liu, Xiaoxi and Vemulapalli, Vidyasiri and Mohseni, Morvarid and Stams, Travis and Buhrlage, Sara J. and Stegmaier, Kimberly and LaMarche, Matthew J. and Acker, Michael G. and Blacklow, Stephen C.},

  abstractNote = {},

  doi          = {10.1016/j.bmc.2017.10.025},

  journal      = {Bioorganic and Medicinal Chemistry},

  number       = 24,

  volume       = 25,

  place        = {United Kingdom},

  year         = {2017},

  month        = {12}

}

Copy to clipboard

Journal Article:

Free Publicly Available Full Text

Accepted Manuscript (Publisher)

Publisher's Version of Record
DOI: 10.1016/j.bmc.2017.10.025

Other availability

Search WorldCat to find libraries that may hold this journal

Citation Metrics:

Cited by: 10 works

Citation information provided by
Web of Science

Save / Share:

Export Metadata

Save to My Library

Similar Records in DOE PAGES and OSTI.GOV collections:

Identification of an allosteric benzothiazolopyrimidone inhibitor of the oncogenic protein tyrosine phosphatase SHP2

Journal Article LaRochelle, Jonathan R. ; Fodor, Michelle ; Ellegast, Jana M. ; ... - Bioorganic and Medicinal Chemistry
DOI: 10.1016/j.bmc.2017.10.025
Salicylic Acid Based Small Molecule Inhibitor for the Oncogenic Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2 (SHP2)

Journal Article Zhang, Xian ; He, Yantao ; Liu, Sijiu ; ... - J. Med. Chem.

The Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2) plays a pivotal role in growth factor and cytokine signaling. Gain-of-function SHP2 mutations are associated with Noonan syndrome, various kinds of leukemias, and solid tumors. Thus, there is considerable interest in SHP2 as a potential target for anticancer and antileukemia therapy. We report a salicylic acid based combinatorial library approach aimed at binding both active site and unique nearby subpockets for enhanced affinity and selectivity. Screening of the library led to the identification of a SHP2 inhibitor II-B08 (compound 9) with highly efficacious cellular activity. Compound 9 blocks growth factor stimulatedmore »« less
DOI: 10.1021/jm901645u
Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase Inhibitor

Journal Article Fortanet, Jorge Garcia ; Chen, Christine Hiu-Tung ; Chen, Ying-Nan P. ; ... - Journal of Medicinal Chemistry

SHP2 is a nonreceptor protein tyrosine phosphatase (PTP) encoded by the PTPN11 gene involved in cell growth and differentiation via the MAPK signaling pathway. SHP2 also purportedly plays an important role in the programmed cell death pathway (PD-1/PD-L1). Because it is an oncoprotein associated with multiple cancer-related diseases, as well as a potential immunomodulator, controlling SHP2 activity is of significant therapeutic interest. Recently in our laboratories, a small molecule inhibitor of SHP2 was identified as an allosteric modulator that stabilizes the autoinhibited conformation of SHP2. A high throughput screen was performed to identify progressable chemical matter, and X-ray crystallography revealedmore »« less
Cited by 72
DOI: 10.1021/acs.jmedchem.6b00680

Full Text Available
Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases

Journal Article Chen, Ying-Nan P. ; LaMarche, Matthew J. ; Chan, Ho Man ; ... - Nature (London)

The non-receptor protein tyrosine phosphatase SHP2, encoded by PTPN11, has an important role in signal transduction downstream of growth factor receptor signalling and was the first reported oncogenic tyrosine phosphatase1. Activating mutations of SHP2 have been associated with developmental pathologies such as Noonan syndrome and are found in multiple cancer types, including leukaemia, lung and breast cancer and neuroblastoma1, 2, 3, 4, 5. SHP2 is ubiquitously expressed and regulates cell survival and proliferation primarily through activation of the RAS–ERK signalling pathway2, 3. It is also a key mediator of the programmed cell death 1 (PD-1) and B- and T-lymphocyte attenuatormore »« less
DOI: 10.1038/nature18621
Mechanistic insights explain the transforming potential of the T507K substitution in the protein-tyrosine phosphatase SHP2

Journal Article Zhang, Ruo-Yu ; Yu, Zhi-Hong ; Chen, Lan ; ... - Journal of Biological Chemistry

The protein-tyrosine phosphatase SHP2 is an allosteric enzyme critical for cellular events downstream of growth factor receptors. Mutations in the SHP2 gene have been linked to many different types of human diseases, including developmental disorders, leukemia, and solid tumors. Unlike most SHP2-activating mutations, the T507K substitution in SHP2 is unique in that it exhibits oncogenic Ras-like transforming activity. However, the biochemical basis of how the SHP2/T507K variant elicits transformation remains unclear. By combining kinetic and biophysical methods, X-ray crystallography, and molecular modeling, as well as using cell biology approaches, in this work we uncovered that the T507K substitution alters bothmore »« less
DOI: 10.1074/jbc.RA119.010274

Similar Records